Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
AEON Biopharma, Inc. | CHIEF EXECTUIVE OFFICER, Director | Stock Option | 1.26M | Aug 31, 2024 | Direct | ||
AEON Biopharma, Inc. | CHIEF EXECTUIVE OFFICER, Director | Class A Common Stock | 751K | Aug 31, 2024 | Direct | ||
AEON Biopharma, Inc. | CHIEF EXECTUIVE OFFICER, Director | Stock Option | 212K | Mar 19, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AEON | AEON Biopharma, Inc. | Aug 31, 2024 | 2 | $0 | 4 | Sep 4, 2024 | CHIEF EXECTUIVE OFFICER, Director |
AEON | AEON Biopharma, Inc. | Mar 19, 2024 | 1 | $0 | 4 | Mar 21, 2024 | CHIEF EXECTUIVE OFFICER, Director |
AEON | AEON Biopharma, Inc. | Jul 21, 2023 | 6 | $0 | 4 | Jul 24, 2023 | Chief Executive Officer, Director |
AEON | AEON Biopharma, Inc. | Jul 21, 2023 | 0 | $0 | 3 | Jul 24, 2023 | Chief Executive Officer, Director |